Familial Mediterranean Fever
34
6
9
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.9%
1 terminated out of 34 trials
92.3%
+5.8% vs benchmark
6%
2 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (34)
A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
AGE and CALLY Index in Familial Mediterranean Fever
is There an Effect of Adding Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean Fever
Outcomes of Inspiratory Muscle Training in FMF Adolescents
Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise
Health-related Quality of Life, Electrocardiographic and Holter Findings in Children With Familial Mediterranean Fever
Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks
Assessment of Cardiorespiratory Fitness Using the PACER in Patients With Juvenile Idiopathic Arthritis and Familial Mediterranean Fever
Caspase-1 Activity, IL-1beta, and IL-18 in Patients With FMF
A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of Life
Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever
Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
Characterization of a Functional Test for Mediterranean Family Fever Screening - 2
Heat Intolerance in the Group of FMF Patients
Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
Physical Abilities of Teenagers With Familial Mediterranean Fever
Assessment of microRNAs Role in Familial Mediterranean Fever FMF Pathophysiology
Evaluation of Bone Metabolism in Children and Adolescents With Familial Mediterranean Fever
A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)
Central Sensitization in Familial Mediterranean Fever (FMF)